CARsgen Therapeutics Holdings Ltd
HKEX:2171
CARsgen Therapeutics Holdings Ltd
HKEX:2171
Price:
24.92
HKD
-6.25%
Market Cap:
HK$14.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
CARsgen Therapeutics Holdings Ltd
HKEX:2171
|
CN |
|
T
|
Trigon Property Development AS
SWB:UG4
|
EE |
|
China Cinda Asset Management Co Ltd
HKEX:1359
|
CN |
|
Fino Payments Bank Ltd
NSE:FINOPB
|
IN |
|
H
|
Haily Group Bhd
KLSE:HAILY
|
MY |
|
Jiangxi Black Cat Carbon Black Inc Ltd
SZSE:002068
|
CN |
Balance Sheet
Balance Sheet Decomposition
CARsgen Therapeutics Holdings Ltd
CARsgen Therapeutics Holdings Ltd
Balance Sheet Decomposition is not available for
CARsgen Therapeutics Holdings Ltd
CARsgen Therapeutics Holdings Ltd
Balance Sheet
CARsgen Therapeutics Holdings Ltd
CARsgen Therapeutics Holdings Ltd
Currency: CNY
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
96
|
1 043
|
691
|
2 268
|
1 850
|
1 479
|
1 123
|
|
| Cash |
0
|
0
|
0
|
0
|
1 850
|
1 479
|
1 123
|
|
| Cash Equivalents |
96
|
1 043
|
691
|
2 268
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
2 316
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
14
|
6
|
49
|
17
|
12
|
33
|
32
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
9
|
16
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
24
|
16
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
7
|
7
|
|
| Other Current Assets |
5
|
7
|
15
|
16
|
11
|
11
|
16
|
|
| Total Current Assets |
115
|
1 056
|
3 071
|
2 301
|
1 873
|
1 530
|
1 178
|
|
| PP&E Net |
172
|
157
|
386
|
441
|
361
|
124
|
98
|
|
| PP&E Gross |
172
|
157
|
386
|
441
|
361
|
124
|
0
|
|
| Accumulated Depreciation |
28
|
62
|
108
|
180
|
259
|
510
|
0
|
|
| Intangible Assets |
28
|
24
|
20
|
14
|
9
|
3
|
1
|
|
| Other Long-Term Assets |
11
|
18
|
28
|
6
|
14
|
16
|
15
|
|
| Total Assets |
326
N/A
|
1 254
+285%
|
3 506
+180%
|
2 763
-21%
|
2 257
-18%
|
1 673
-26%
|
1 292
-23%
|
|
| Liabilities | ||||||||
| Accrued Liabilities |
39
|
57
|
94
|
137
|
151
|
171
|
138
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
30
|
74
|
233
|
22
|
15
|
34
|
13
|
|
| Other Current Liabilities |
953
|
14
|
61
|
12
|
31
|
49
|
54
|
|
| Total Current Liabilities |
1 021
|
145
|
389
|
171
|
196
|
254
|
205
|
|
| Long-Term Debt |
21
|
26
|
105
|
97
|
70
|
133
|
48
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Other Liabilities |
16
|
2 759
|
15
|
21
|
189
|
230
|
259
|
|
| Total Liabilities |
1 058
N/A
|
2 930
+177%
|
509
-83%
|
290
-43%
|
456
+57%
|
616
+35%
|
509
-17%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
683
|
1 712
|
6 468
|
7 316
|
8 049
|
8 838
|
783
|
|
| Additional Paid In Capital |
0
|
0
|
9 420
|
9 430
|
9 437
|
9 388
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
49
|
35
|
44
|
359
|
414
|
507
|
0
|
|
| Total Equity |
733
N/A
|
1 676
-129%
|
2 997
N/A
|
2 473
-17%
|
1 802
-27%
|
1 057
-41%
|
783
-26%
|
|
| Total Liabilities & Equity |
326
N/A
|
1 254
+285%
|
3 506
+180%
|
2 763
-21%
|
2 257
-18%
|
1 673
-26%
|
1 292
-23%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
567
|
567
|
568
|
573
|
576
|
572
|
570
|
|
Switch to:
Switch to:
See Also
Discover More
